Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 9, 665-668, November 1, 1949]
© 1949 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dillard, G. H. L.
Right arrow Articles by Chanutin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dillard, G. H. L.
Right arrow Articles by Chanutin, A.

The Protease and Antiprotease of Plasmas of Patients with Cancer and Other Diseases*

George H. L. Dillard and Alfred Chanutin

(From the Biochemical Laboratory, Medical School, University of Virginia, Charlottesville, Va.)

The activities of choroform activated plasmin, spontaneously active protease (proteolysin) and trypsin inhibitor of the plasma of healthy young men and of patients with cancer and with a variety of acute and chronic diseases were determined.

Observations made on a group of patients shortly after admission to the hospital showed elevated values for the proteolysin and trypsin inhibitor in most cases. No relationship between plasmin, proteolysin, and inhibitor concentrations could be established.

Periodic analyses of the proteolysin and trypsin inhibitor were made on patients (a) after incomplete removal of cancer, (b) after complete removal of cancer, (c) during recovery from pneumonia, and (d) with a variety of chronic diseases. The proteolysin concentration dropped to zero soon after complete surgical removal of a cancer, and in other cases after successful therapy or surgery. The tryspin inhibitor remained elevated for an appreciable period.

The appearance of proteolysin in plasma is associated with necrosis and with inflammatory processes accompanied by elevated temperatures. The trypsin inhibitor concentration remains elevated in patients who have been operated on and in those whose tissues are undergoing readjustment to the normal state.

The significance of the changes noted in the plasmas of diseased individuals is discussed.




This article has been cited by other articles:


Home page
Arch Intern MedHome page
M. S. SIRRIDGE, K. S. BOWMAN, and P. E. GARBER
Fibrinolysis and Changes in Fibrinogen in Multiple Myeloma
Arch Intern Med, March 1, 1958; 101(3): 630 - 635.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1949 by the American Association for Cancer Research.